Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
about
Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III)Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and reviewThe role of systemic treatment before, during, and after definitive treatmentThe Indian scenario of head and neck oncology - Challenging the dogmasAn update on larynx cancerDifference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitantUp-front and Salvage Transoral Robotic Surgery for Head and Neck Cancer: A Belgian Multicenter Retrospective Case SeriesFunctional organ preservation in laryngeal and hypopharyngeal cancer.A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.Role of surgery in the management of head and neck cancer: a contemporary view of the data in the era of organ preservation.Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.Organ preservation by transoral laser microsurgery in piriform sinus carcinoma.High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. ELong-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservationRecent advances in management of laryngeal cancerSurvival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerSquamous cell carcinomas of the head and neck.Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy.Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers.Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.Concurrent radiochemotherapy in advanced hypopharyngeal cancerIntensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancerHistologically negative specimens after induction therapy: frequency and impact on survival.New therapeutic strategies for the treatment and prevention of head and neck cancer.[Multimodal laryngeal preservation: current data-based opinion].Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research SubcommitteeQuality of life for patients with hypopharyngeal cancer after different therapeutic modalities.Role of multimodal treatment in oropharynx, larynx, and hypopharynx cancer.Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience.
P2860
Q24803870-0D7D015A-B319-40D6-B693-A4CDC7B4A133Q26798275-6580ABEF-9ADF-4866-B2C4-0318D4BDD683Q26859285-4701DAC9-23F6-44EA-A310-0F53F7868C93Q28072546-8D55D465-0DD9-44B8-A691-DC897F43FFB4Q28079132-9D46C9EE-56A8-45B6-BFBF-F95DA1C31539Q28236344-1C1236FE-7089-4A72-8C87-B05B2A1B0307Q30399047-5D9C136E-6777-4740-9350-2EE3A20864A5Q30467853-E7E35279-A1A2-4290-9D48-AEEC7FDCC496Q30487675-6236111B-327C-48C6-8CD8-D429FF0DDCABQ30585078-8DEE8368-E05F-4E50-9019-1ED36A53AD07Q31063952-BEDE2429-AB49-4F8E-BC69-7BAC0CC3BBBBQ31875711-5CE3E189-EF85-45E7-95BE-BFA1D9B36C57Q33328454-31E1856D-0580-4120-9250-3A0863D71EECQ33335541-39020334-EF13-4DB6-98DC-4C2E6E17BB63Q33343214-08608FFA-238A-430B-BC65-618967E80BE5Q33343271-0357C855-EA96-4D5A-8B69-42280644EE59Q33344718-5673DAFF-F46B-475D-BE85-3EE3E5718C87Q33380006-A72FCABB-FE9A-442F-A55B-015076C98488Q33383864-BE7E06AA-4B11-479D-A89F-D33A38CDEB1CQ33386187-D06BDFA7-534F-4D09-AA14-81BCC3D88462Q33393655-AE824CA6-A7E1-45C9-995B-39A0CCC28F48Q33542810-20D1E89C-7D82-499E-8877-216E24278E2DQ33557030-80831D8C-2FAA-4F33-9DAB-4FE5F46557CAQ33711438-8E0AF047-6F54-4989-9E6D-2D069907D854Q33812371-9917EDE4-535D-4CFC-8A6C-E7B324C40549Q33870104-F9D0FC1C-5659-4253-966E-520041BFAC03Q33875427-A01C19FF-92CC-4A30-A758-E5E7C86FF7B7Q33918767-D99413C3-C83B-45E2-B87C-0B17278A43EEQ33931220-332B0BDF-BBA5-4747-8887-C3BC724E0BE7Q33933913-E8D9BE97-D30D-4A14-9E33-9895863FAC28Q34085695-3D09A6C5-E870-495A-9E61-E17DA6F9DB86Q34090976-1A60BF23-7E45-47DD-8D3D-87715889E75BQ34142639-A20651FA-67CB-4C7B-81B9-F1C2E5AE436BQ34160540-2142789D-9A30-421C-B3EB-88A1F1CB181EQ34172866-BA6DBA0B-8BCA-4D3B-9463-5B0DDB29F302Q34210492-8BA9C6E9-516A-493D-91E5-D51DE8DD4E2FQ34221226-D0793F86-ED42-468E-AF47-3F94FAFD96EDQ34278528-98762314-690B-4828-B36C-C4BCFFE939F2Q34315576-9E94E2A0-02E6-4FB9-97CB-CAFADDDA5372Q34408305-D97931FE-655A-48C4-905D-CDC43334804B
P2860
Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Larynx preservation in pyrifor ...... Neck Cancer Cooperative Group.
@en
type
label
Larynx preservation in pyrifor ...... Neck Cancer Cooperative Group.
@en
prefLabel
Larynx preservation in pyrifor ...... Neck Cancer Cooperative Group.
@en
P2093
P356
P1476
Larynx preservation in pyrifor ...... Neck Cancer Cooperative Group.
@en
P2093
Chevalier D
Collette L
Kirkpatrick A
Lefebvre JL
Luboinski B
P304
P356
10.1093/JNCI/88.13.890
P407
P577
1996-07-01T00:00:00Z